Can I take magnesium glycinate 120 mg with sick sinus syndrome-associated bradycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Magnesium Glycinate 120 mg is Safe in Sick Sinus Syndrome

Magnesium glycinate 120 mg can be safely taken in patients with sick sinus syndrome and bradycardia, as magnesium supplements are not listed among medications that cause or exacerbate sinus node dysfunction. 1

Medications to Avoid in Sick Sinus Syndrome

The ACC/AHA/HRS guidelines explicitly identify drugs that must be eliminated in patients with sick sinus syndrome because they directly depress sinus node function: 2, 1

  • Beta-blockers are contraindicated and should be discontinued 1
  • Non-dihydropyridine calcium channel blockers (verapamil, diltiazem) are contraindicated unless a functioning pacemaker is already in place 1
  • Digoxin and cardiac glycosides must be avoided as they exacerbate sinus node dysfunction 1
  • Class IC antiarrhythmic agents and other membrane-active antiarrhythmics should be eliminated 1
  • Other agents including lithium, methyldopa, risperidone, cisplatin, and interferon can worsen bradycardia 2, 1

Why Magnesium is Safe

Magnesium supplements, including magnesium glycinate, do not appear on the comprehensive list of medications that cause or worsen sinus node dysfunction in the 2018 ACC/AHA/HRS bradycardia guidelines. 2, 1 The systematic medication review algorithm for sick sinus syndrome specifically targets agents that depress sinus node activity, and magnesium is not among them. 1

Important Distinction: Dihydropyridine vs Non-Dihydropyridine Calcium Channel Blockers

A common pitfall is confusing different classes of calcium channel blockers: 1

  • Dihydropyridine agents (amlodipine, nifedipine) are safe in sick sinus syndrome
  • Non-dihydropyridine agents (verapamil, diltiazem) are contraindicated

Magnesium does not function as a calcium channel blocker in the same manner as these pharmaceutical agents and does not suppress sinus node automaticity. 2

Management Algorithm for Sick Sinus Syndrome

Before attributing symptoms to intrinsic sinus node disease, the guidelines recommend: 2, 1

  1. First step: Systematically review and eliminate all medications that depress sinus node activity (beta-blockers, non-dihydropyridine calcium channel blockers, digoxin, antiarrhythmics) 1

  2. Second step: Assess for reversible metabolic contributors including hypothyroidism, electrolyte disturbances (potassium abnormalities), hypoxemia, and acute infections 2, 1

  3. Third step: If symptoms persist after addressing reversible causes and the patient has documented symptomatic bradycardia, permanent pacemaker implantation becomes the definitive therapy 2, 3

Clinical Context

The 120 mg dose of magnesium glycinate is a modest supplemental dose, well below levels that would cause systemic effects on cardiac conduction. 2 Magnesium deficiency itself can contribute to arrhythmias, and maintaining adequate magnesium levels is generally beneficial for cardiac health without suppressing sinus node function. 2

In summary, you can safely continue magnesium glycinate 120 mg with sick sinus syndrome, but ensure you are not taking any of the contraindicated medications listed above. 1

References

Guideline

Medication Management in Bradycardia and Sick Sinus Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Sick Sinus Syndrome and Tachy-Brady Syndrome Relationship

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.